U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H16N4O8S2
Molecular Weight 516.504
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of NITROCEFIN

SMILES

OC(=O)C1=C(CS[C@@H]2[C@H](NC(=O)CC3=CC=CS3)C(=O)N12)\C=C\C4=C(C=C(C=C4)[N+]([O-])=O)[N+]([O-])=O

InChI

InChIKey=LHNIIDJCEODSHA-OQRUQETBSA-N
InChI=1S/C21H16N4O8S2/c26-16(9-14-2-1-7-34-14)22-17-19(27)23-18(21(28)29)12(10-35-20(17)23)4-3-11-5-6-13(24(30)31)8-15(11)25(32)33/h1-8,17,20H,9-10H2,(H,22,26)(H,28,29)/b4-3+/t17-,20-/m1/s1

HIDE SMILES / InChI

Description

Nitrocefin is a chromogenic cephalosporin substrate routinely used to detect the presence of beta-lactamase enzymes produced by various microbes. Intact beta-lactam antibiotics act as an analog to penicillin-binding proteins (PBPs) involved in peptidoglycan synthesis. Beta-lactamases hydrolyze the amide bond between the carbonyl carbon and the nitrogen in the beta-lactam ring of susceptible beta-lactams and members of beta-lactam subclasses (including certain cephalosporins). After hydrolysis of the amide bond, the antibiotic lacks the ability to mimic bacterial PBPs and is rendered useless. Visual detection of this process is essentially impossible with most cephalosporins because the shift of ultraviolet absorption from the intact versus hydrolyzed product occurs outside of the visible spectrum. Hydrolysis of nitrocefin, however, produces a shift of ultraviolet absorption inside the visible light spectrum from intact (yellow) nitrocefin (~380 nm) to degraded (red) nitrocefin (~500 nm) allowing visual detection of beta-lactamase activity on a macroscopic level.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
A working solution of Nitrocefin is prepared by adding 0.5 ml of dimethyl sulfoxide to 5 mg of Nitrocefin powder. A 9.5-ml amount of 0.1 M phosphate buffer (pH 7.0) is added to provide a final Nitrocefin concentration of 500mkg/ml. The solution is dispensed in 0.5-ml portions and frozen at -20°C. A loopful of the test organism is removed from colonial growth on the surface of a brucella blood agar plate and emulsified in one drop of the Nitrocefin solution on a clean glass microscope slide. A change in color from yellow to red within 15 min indicates a positive reaction.